Recon: BMS inks $380M CAR-T manufacturing deal with Cellares; Supreme Court tosses out Vanda’s sleep disorder drug patent case
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States